Utilizing continuous glucose monitoring in primary care practice: What the numbers mean

During the past five years, there has been an upsurge in use of continuous glucose monitoring (CGM) among individuals with type 1 diabetes [1]. The clinical benefits of CGM has been demonstrated in numerous studies of individuals with T1D regardless of insulin delivery method [2 –17]. The benefits of CGM use in this population include reductions in A1C [2,4,6,12,13,18–22], fewer severe hypoglycemia events [19,20,23], increased time within target glucose range (TIR) [6,13,14,24] and reductions in time below range [TBR] [6,13].

Source: Primary Care Diabetes - November 28, 2020 Category: Primary Care Authors: Steven V. Edelman, Tricia Santos Cavaiola, Schafer Boeder, Jeremy Pettus Tags: Review Source Type: research